innoscripta Aktie
| 115,60EUR | -1,40EUR | -1,20% | 
WKN DE: A40QVM / ISIN: DE000A40QVM8
Personal
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Umlaufvermögen | 17 | 29 | 35 | 58 | 
| Summe Anlagevermögen | 0 | 1 | 1 | 1 | 
| Summe Aktiva | 17 | 30 | 35 | 59 | 
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Fremdkapital | 7 | 17 | 17 | 24 | 
| Summe Eigenkapital | 11 | 13 | 18 | 35 | 
| Summe Passiva | 17 | 30 | 35 | 59 | 
Adresse
| Arnulfstrasse 60, 80335 Munich | |
| Telefon | +49 (89) 25555-3537 | 
| Internet | http://www.innoscripta.com | 
Management
| Alexander Meyer Chief Financial Officer | 
| Christoph Möller Deputy Chairman-Supervisory Board | 
| Duygu Uysal Member-Supervisory Board | 
| Erik Massmann Member-Supervisory Board | 
| Kai Andrejewski Member-Supervisory Board | 
| Michael Georg Hohenester Chief Executive Officer | 
| Philipp von Ilberg Chairman-Supervisory Board | 
| Sebastian Schwertlein Chief Operating Officer | 
| Stefan Berndt-von Bülow Member-Supervisory Board | 
 
									 
									 
								